Overview

AVS After 1mg DST to Determine Subtype in PA

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
To compare the effect of different procedures of AVS(after 1mg DST or not) in determining the subtypes and long-term outcomes of PA
Phase:
N/A
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Treatments:
Dexamethasone